Evidence map›Paper›PMID 41561101›Full record

ArticleERJ open research2026

Adult male patients with

Ophélie Evrard, Quentin Philippot, Caroline Kannengiesser, Marie Pierre Debray, Alice Guyard, Antonin Fattori, Armelle Schuller, Hilario Nunes, David Montani, Vincent Bours and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Ophélie EvrardLaboratoire de Génétique, Hôpital Bichat Claude Bernard, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.ORCID https://orcid.org/0009-0004-9782-4387
Quentin PhilippotService de Pneumologie, allergologie et transplantation, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Caroline KannengiesserLaboratoire de Génétique, Hôpital Bichat Claude Bernard, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.ORCID https://orcid.org/0000-0003-2155-9383
Marie Pierre DebrayINSERM U1149 Centre de Recherche de l'Inflammation, Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0003-2109-5662
Alice GuyardDépartement de Pathologie, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.
Antonin FattoriDépartement de Pathologie, Hôpital Hautepierre, Centre hospitalier universitaire (CHU) Strasbourg, Strasbourg, France.
Armelle SchullerService de pneumologie, CHU Strasbourg, Strasbourg, France.
Hilario NunesINSERM UMR 1272, Université Sorbonne Paris Nord, Service de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares, Hôpital Avicenne, AP-HP, Bobigny, France.
David MontaniDepartment of Pneumology and Intensive Care Medicine, Hospital Bicêtre, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-9358-6922
Vincent BoursService de Génétique Humaine, CHU Liège et GIGA, University of Liège, ERN GENTURIS, Liege, Belgium.
Vincent CottinNational Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, ERN-LUNG, Lyon, France.ORCID https://orcid.org/0000-0002-5591-0955
Julie TracletNational Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon 1, UMR 754, ERN-LUNG, Lyon, France.
Amira BenattiaService de Pneumologie, Hôpital Saint Louis, AP-HP, Paris, France.
Emilie BerthouxService de Médecine Interne, Hôpital Saint Joseph Saint Luc, Lyon, France.
Adrien DanielService d'hématologie, CH de Dunkerque, Dunkerque, France.
Xu Yan-MinService de Pneumologie, CHU d'Orléans, Orleans, France.
Elodie LaineyService d'Hématologie Biologique, Hôpital Robert Debré, AP-HP, UMRS 1131, IUH, Paris, France.
Julien SaussereauDepartment of Pneumology, Institut Mutualiste Montsouris, Paris, France.
Malika Chelbi ViallonLaboratoire de Génétique, Hôpital Bichat Claude Bernard, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.
Claire OudinLaboratoire de Génétique, Hôpital Bichat Claude Bernard, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.
Héléne MorelLaboratoire de Génétique, Hôpital Bichat Claude Bernard, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.ORCID https://orcid.org/0000-0002-7663-8380
Bruno CrestaniService de Pneumologie, allergologie et transplantation, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.ORCID https://orcid.org/0000-0002-2961-3455
Raphaël BorieService de Pneumologie, allergologie et transplantation, Hôpital Bichat Claude Bernard, AP-HP, Paris, France.ORCID https://orcid.org/0000-0002-9906-0024
Ibrahima BaLaboratoire de Génétique, Hôpital Bichat Claude Bernard, Assistance publique-hôpitaux de Paris (AP-HP), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mutations in telomere-related genes (TRGs) are the main cause of monogenic familial pulmonary fibrosis. Dyskerin, encoded by the X-localised gene Methods: This retrospective study aimed to further characterise the pulmonary phenotype of Results: We reported eight, as yet undescribed, to our knowledge, probands affected by pulmonary fibrosis associated with X-linked Conclusions: Compared with patients with pulmonary fibrosis associated with other TRG variants, those with pulmonary fibrosis associated with X-linked recessive

Identifiers

PMID41561101
PMCPMC12813686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.